These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 8281054)
1. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. Brennan M; Runganga J; Barbara JA; Contreras M; Tedder RS; Garson JA; Tuke PW; Mortimer PP; McAlpine L; Tosswill JH BMJ; 1993 Nov; 307(6914):1235-9. PubMed ID: 8281054 [TBL] [Abstract][Full Text] [Related]
2. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires]. Blejer JL; Saguier MC; Salamone HJ; Carreras LA Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226 [TBL] [Abstract][Full Text] [Related]
3. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil. Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia. Ul-Hassan Z; Al-Bahrani AT; Panhotra BR Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814 [TBL] [Abstract][Full Text] [Related]
5. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey]. Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970 [TBL] [Abstract][Full Text] [Related]
6. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant? Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617 [TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France. Couroucé AM; Pillonel J; Lemaire JM; Maniez M; Brunet JB AIDS; 1993 Jun; 7(6):841-7. PubMed ID: 8103342 [TBL] [Abstract][Full Text] [Related]
8. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. The HTLV European Research Network. J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep; 13(1):68-77. PubMed ID: 8797688 [TBL] [Abstract][Full Text] [Related]
9. HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil. Farias de Carvalho SM; Pombo de Oliveira MS; Thuler LC; Rios M; Coelho RC; Rubim LC; Silva EM; Reis AM; Catovsky D J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):238-42. PubMed ID: 9257659 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires. Gutfraind Z; Blejer JL; Saguier MC; Gómez Carretero ML; Pirola DA; Carreras Vescio LA Medicina (B Aires); 1995; 55(4):295-9. PubMed ID: 8728867 [TBL] [Abstract][Full Text] [Related]
11. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia. Fawaz NA; Tamim H; Almawi WY Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675 [TBL] [Abstract][Full Text] [Related]
12. Confirming the presence of HTLV-1 infection and the absence of HTLV-2 in blood donors from Arequipa, Peru. Quispe NC; Feria EB; Santos-Fortuna Ede L; Caterino-de-Araujo A Rev Inst Med Trop Sao Paulo; 2009; 51(1):25-9. PubMed ID: 19229387 [TBL] [Abstract][Full Text] [Related]
13. HTLV-I/II infections in Spain. The HTLV-I/II Spanish Study Group. Soriano V; Calderón E; Esparza B; Cilla G; Aguilera A; Gutiérrez M; Tor J; Pujol E; Merino F; Pérez-Trallero E Int J Epidemiol; 1993 Aug; 22(4):716-9. PubMed ID: 8225748 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of HTLV-I/II antibodies in HIV seropositive and HIV seronegative STD patients in Vellore region in southern India. Babu PG; Ishida T; Nesadoss J; John TJ Scand J Infect Dis; 1995; 27(2):105-8. PubMed ID: 7660071 [TBL] [Abstract][Full Text] [Related]
15. Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand. Oota S; Chaiwong K; Pikulsod S; Khuenkaew R; Pheakkhuntod S; Rattajak P; Kramkratok P; Shiu C; Bhatnagar S; Sakuldamrongpanich T Pathog Glob Health; 2018 Oct; 112(7):343-348. PubMed ID: 30424716 [TBL] [Abstract][Full Text] [Related]
16. Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009. Carneiro-Proietti AB; Sabino EC; Leão S; Salles NA; Loureiro P; Sarr M; Wright D; Busch M; Proietti FA; Murphy EL; AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1265-72. PubMed ID: 22324906 [TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal. Diop S; Calattini S; Abah-Dakou J; Thiam D; Diakhaté L; Gessain A J Clin Microbiol; 2006 Apr; 44(4):1550-4. PubMed ID: 16597891 [TBL] [Abstract][Full Text] [Related]
18. [HTLV-I/II seroprevalence and risk factors associated with infection in a blood donor population in Córdoba, Argentina]. Gallego S; Maturano E; Recalde A; Gastaldello R; Sileoni S; Bepre H; Medeot S Rev Argent Microbiol; 2001; 33(3):182-6. PubMed ID: 11594010 [TBL] [Abstract][Full Text] [Related]
19. [Epidemiologic study of anti-HTLV-I/II antibodies in blood donors in metropolitan France. The Retrovirus Working Group of the National Blood Transfusion Society]. Lemaire JM; Coste J; Barin F; Couroucé AM Rev Fr Transfus Hemobiol; 1991 Jan; 34(1):21-34. PubMed ID: 2015034 [TBL] [Abstract][Full Text] [Related]
20. Is seroprevalence of HTLV-I/II among blood donors in India relevant? Kumar H; Gupta PK Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]